Search results
FDA approves first RSV vaccine for at-risk adults in their 50s
CBS News· 3 days agoTwo other companies – Pfizer and Moderna – also manufacture RSV vaccines approved for adults 60 and...
mRESVIA’s FDA approval paves the way for mRNA vaccines across multiple indications
Clinical Trials Arena via Yahoo Finance· 4 days agoHowever, mRESVIA...mRESVIA is the only RSV product available in a single-dose prefilled syringe,...
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
CNBC· 3 days agoThe Food and Drug Administration on Friday expanded the approval of GSK's respiratory syncytial...
Chronotherapy: Why Timing Drugs to Our Body Clocks May Work
Medscape· 10 hours agoA new analysis published in this month's issue of The Lancet journal's eClinicalMedicine suggests:...
The Chicken and Egg Problem of Fighting Another Flu Pandemic
The Weatherford Democrat· 6 days agoAdvanced Research and Development Authority (BARDA) during the Trump administration. It’s not so...
Crinetics Stock: Pharma Firm Unveils 'Stunning' Results In Major Study
Investor's Business Daily· 7 days ago"I've never seen anything like it," Chief Executive Scott Struthers told Investor's Business Daily...
FDA panel recommends new COVID-19 vaccine formula for fall
UPI· 4 days agoDr. Peter Marks, who oversees the FDA's vaccine division, urged the committee to consider...
The chicken and egg problem of fighting another flu pandemic
The Columbian· 1 day agoIt’s not so funny, he said, when the currently stockpiled formulation against the H5N1 bird flu virus requires two shots and a whopping 90 micrograms of antigen, yet provides ...
Scientists are testing vaccines to protect cows and people against bird flu
Temple Daily Telegram· 6 days agoThe bird flu outbreak in U.S. dairy cows is prompting development of new, next-generation mRNA ...
How Messenger RNA Made The COVID Vaccines Possible
Science Friday· 3 days agoThe following is an excerpt from The Catalyst: RNA and the Quest to Unlock Life’s Deepest Secrets by Thomas R. Cech. On January 10, 2020, Prof. Yong-Zhen Zhang of Fudan University in Shanghai ...